Pharmaceuticals & Therapeutics

With a new CEO from rival InMode and backing from a global powerhouse, Boston Aesthetics is poised to shake up the competitive medical aesthetics industry.

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

With the key hire of a new commercial VP, Grey Wolf Animal Health aims to unlock synergies between its booming pharmacy and animal health divisions.

With promising Phase 2 data for its novel peptide therapies, Sapience Therapeutics is engaging investors, signaling a critical push for future growth.

A new partnership introduces PBSerum®, a biologically inspired enzyme treatment, aiming to redefine skin quality in the multi-billion dollar aesthetics market.

IVY Rx unveils its 2026 compounded GLP-1 program with clear pricing, but operates in a market facing intense FDA warnings and regulatory uncertainty.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

A jury found Abbott's Similac caused a fatal gut disease in premature infants, igniting a legal firestorm over what the formula giant knew and when.

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

A group known for challenging pandemic rules will now advise on US vaccine policy. Can it rebuild trust, or will it deepen the medical divide?

A new partnership between a Chinese biotech and a Brazilian public institute aims to slash the $500k cost of CAR-T therapy, making it accessible to all.

My Derma Dream's MyoGlow promises a surgery-free arm lift. We investigate the science, the marketing, and the guarantee fine print consumers must see.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

A new natural suppository aims to break the cycle of recurrent yeast infections by supporting the vaginal microbiome, offering hope to millions of women.

Florida's Dunamis Premium Spirits is making waves, targeting the global cruise market with its award-winning, mission-driven brands. Here's how.

With Nuvaxovid set for a 2026 rollout, Sanofi aims to address vaccine hesitancy and expand choices as Canada continues to battle the virus.

With a personal family connection to type 1 diabetes and a £100M war chest, Anastasia Bukhman joins the T1D Fund's board to speed up research.

A new non-invasive therapy using ultrasound to activate a cancer-targeting drug enters a crucial Phase 2b trial, offering new hope for glioblastoma patients.

1 Hotel Hanalei Bay blends cutting-edge biohacking with the raw power of nature, aiming to redefine luxury wellness. Is this the future of health travel?